Laddar...
Bullous Skin Rash: A Rare Case of Palbociclib-Induced Dermatological Toxicity
Palbociclib is an FDA-approved cyclin-dependent kinase inhibitor to treat hormone-positive, HER2-negative metastatic breast cancer. Severe skin toxicities are rare but important adverse events associated with these agents. Early detection of severe forms of skin lesions is crucial to permit the imme...
Sparad:
| I publikationen: | Cureus |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Cureus
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474565/ https://ncbi.nlm.nih.gov/pubmed/32913695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10229 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|